Welcome to Browse Page of Biomarker

This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.

The total number entries retrieved from this search are 6
Please click on Biomarker_ID to view detailed information.
Note: Potential Biomarker with * indicates these signatures are candidate biomarkers extracted from experiments on mice, rat or cell lines and they are not validated on human patients'cohort.
Biomarker IDBiomarkerBiomoleculeSubjectRegulationBiomarker's typeExperimentLevel of significanceSourcePMID
2356PTPRDRNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.15) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2436TPRRNAsHumanUpregulated in highly invasive HCC than less-invasive HCC (with fold change of 1.86 ) Prognosticless (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients p < 0.01Tissue19945130
2531TRIM25, EIF2S3, CLECSF14, DXYS155E, T-cell receptor beta locus, GIF2H2, SPON2, VDAC2, SLC15A3, HBP1, PTPRC, FES, CDC5L, ITGB2, MPP1, NDUFA2, AHCYL1, CNP, SQLE, RPA3, LGALS1, HLA-DQA1 , STMN1, PCOLCE, LOC387680, DPT, SLK, IGBP1, SNRPG, Human-alpha1-antitrypsin gene (S variant) complete cds, SIAHBP1, RNAsHuman7 genes Downregulated i.e. CYP1A2, Human-alpha1-antitrypsin gene (S variant) complete cds, PCOLCE, CNP, DXYS155E, CLECSF14, TRIM25 and 29 get upregulated in Diagnostic and prognosticSingle nodular HCC group v/s multicentric HCC group; associated with multicentric recurrence p < 0.05Tissue16788756
2547FBN1, MEF2C, TNFAIP3, LAPTM5, TMSB4X, CUGBP2, HLA-DRA, REL, clone110298, LTBP2, TRIM22, HLA-DRBI, FOXF1, HLA-DQA, SDF1, DDX17, SGK, PDGFRA, F2R, HLADG, MTAP44, CTSK, VIM, ACVR1, ON/SPARC, SCYA3, ARHGEF6, CCND2, COL1A1, ITGB2/CD18, PTPRC, MKNK1, JUNB, EST, GATA6, FUT3, RDBP, E48, SEMA3F, COL6A3, GBAPRNAsHuman 11 genes (FUT3, RDBP, E48, SEMA3F, COL6A3, GBAP, FUT1, GCHFR, CYP2A, MLH1, EST) Upregulated and rest 35 genes downregulated in HCC with early IHR vs. HCC without recurrence PrognosticIntrahepatic recurrence v/s Non-recurrence p < 0.05Tissue15688398
2556VAMP2, ALDH3A2, DPP4, CCL3, HAPLN1, MAN2B1, RBPMS, ACSL6, ITPR2, PLEKHM2, RNF115, CIC, CALR, CENPNRNAsHumanDifferentially expressed gene Prognosticcirrhotic liver tissues with and without hepatocellular carcinoma; can predict prognosis of HCC p < 0.01Tissue19861515
2573BMP4, FLNB, GNG11, GFR, and PTPRKRNAsHumanUpregulated in HBV-HCCs from patients with LC DiagnosticHBV-HCCs patients with LC (liver cirrhosis) vs without LC (liver cirrhosis) P< 0.05Tissue12771952

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top